Angioplasty Balloons Market Size & Share, By Type (Normal, DEB, Cutting, Scoring), Application (Peripheral, Coronary), End-use (Hospitals, ASCs, Cath Labs) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 4039| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Angioplasty Balloons Market size is predicted to reach USD 3.83 billion by 2034, up from USD 2.61 billion in 2024, reflecting a CAGR of over 3.9% during the forecast period from 2025 to 2034. The industry revenue for 2025 is projected to be USD 2.7 billion.

Base Year Value (2024)
USD 2.61 billion
CAGR (2025-2034)
3.9%
Forecast Year Value (2034)
USD 3.83 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Angioplasty Balloons Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: One major growth driver for the Angioplasty Balloons Market is the increasing prevalence of cardiovascular diseases worldwide. With the rise in sedentary lifestyles, unhealthy eating habits, and aging population, the incidence of heart-related conditions such as coronary artery disease and heart attacks is on the rise. This has led to a growing demand for minimally invasive procedures such as angioplasty, where balloons are used to open up blocked blood vessels and improve blood flow to the heart. Another key growth driver for the Angioplasty Balloons Market is technological advancements in balloon catheter design and materials. Manufacturers are continuously innovating to develop balloons with improved flexibility, trackability, and durability. These advancements have allowed for better clinical outcomes, reduced procedural complications, and increased patient satisfaction. As a result, healthcare providers are increasingly adopting these advanced angioplasty balloons, driving market growth. The third major growth driver for the Angioplasty Balloons Market is the expanding healthcare infrastructure and increasing healthcare expenditure in emerging economies. Countries such as China, India, and Brazil are witnessing rapid urbanization, economic development, and improvements in healthcare access. This has led to a greater demand for cardiovascular interventions, including angioplasty procedures. As these markets continue to grow, the demand for angioplasty balloons is expected to rise significantly. Industry Restraints: One major restraint for the Angioplasty Balloons Market is the high cost of angioplasty procedures and associated devices. While angioplasty is considered a minimally invasive and cost-effective alternative to traditional open-heart surgery, the overall cost of the procedure can still be a barrier for many patients, particularly in developing countries. Additionally, the cost of advanced angioplasty balloons with innovative features can be prohibitive for some healthcare facilities, limiting their adoption and market growth. Another key restraint for the Angioplasty Balloons Market is the risk of complications and restenosis associated with balloon angioplasty. Despite technological advancements, there is still a risk of complications such as vessel dissection, embolization, and vessel perforation during the procedure. Moreover, restenosis, or the re-narrowing of the treated blood vessel, can occur in a significant number of patients after angioplasty. These complications can impact patient outcomes, increase healthcare costs, and deter healthcare providers from performing angioplasty procedures, thereby restraining market growth.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Angioplasty Balloons Market
Largest Region
North America
41% Market Share in 2024
Angioplasty Balloons Market Regional Analysis: North America (U.S., Canada): - The North America angioplasty balloons market is expected to show steady growth due to the increasing prevalence of cardiovascular diseases in the region. - The United States and Canada are the major countries contributing to the market growth in North America. - Technological advancements in angioplasty balloons, favorable reimbursement policies, and the presence of key market players are driving the market growth in this region. Asia Pacific (China, Japan, South Korea): - The Asia Pacific angioplasty balloons market is projected to witness significant growth during the forecast period. - China, Japan, and South Korea are the key countries driving market growth in the Asia Pacific region. - Rising healthcare spending, increasing prevalence of coronary artery disease, and growing awareness about minimally invasive procedures are contributing to the market growth in this region. Europe (United Kingdom, Germany, France): - The Europe angioplasty balloons market is expected to grow at a moderate rate, with the United Kingdom, Germany, and France being the major contributors. - The presence of well-established healthcare infrastructure, increasing geriatric population, and rising adoption of advanced medical technologies are driving the market growth in Europe. - However, stringent regulatory policies and reimbursement issues may hinder market growth to some extent in this region.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Angioplasty Balloons Market Size & Share Normal Angioplasty Balloons: The normal angioplasty balloons segment holds a significant share in the market due to their widespread use in various applications such as peripheral and coronary interventions. These balloons provide support in dilating the narrowed or blocked arteries, thereby improving blood flow. Drug-Eluting Balloons (DEB): The DEB segment is expected to witness a high growth rate in the market, attributed to their ability to deliver anti-proliferative drugs directly to the target site, reducing the risk of restenosis. The increasing adoption of DEBs in coronary and peripheral interventions is fueling the segment's growth. Cutting Angioplasty Balloons: Cutting angioplasty balloons are designed with microsurgical-like blades to remove the plaque from the artery walls during the procedure. This segment is gaining traction in the market as it provides a more precise and efficient method of plaque removal compared to traditional angioplasty balloons. Scoring Angioplasty Balloons: Scoring angioplasty balloons segment is also witnessing growth, primarily driven by their ability to create grooves in the plaque, facilitating better expansion and establishment of stent apposition. These balloons are increasingly used in complex coronary interventions, contributing to the segment's market share. Peripheral Application: The peripheral application segment dominates the market share, attributed to the rising prevalence of peripheral artery disease (PAD) and the increasing demand for minimally invasive procedures to treat these conditions. Angioplasty balloons are extensively used in peripheral interventions, contributing to the segment's growth. Coronary Application: The coronary application segment is also witnessing significant growth in the market, driven by the increasing incidence of coronary artery disease (CAD) and the advancements in angioplasty techniques. The demand for coronary angioplasty balloons is on the rise, particularly in cath labs and hospitals. Hospitals End-use: Hospitals are the major end-users of angioplasty balloons, owing to the high patient footfall for cardiovascular interventions and the availability of advanced medical facilities. The hospitals segment holds a significant market share and is expected to continue its dominance in the coming years. Ambulatory Surgical Centers (ASCs): ASCs are gaining traction as end-users of angioplasty balloons, attributed to their cost-effective nature and convenience for patients undergoing minimally invasive procedures. The ASCs segment is expected to witness steady growth in the market share, driven by the increasing preference for outpatient settings for cardiovascular interventions. Cath Labs: Cath labs play a crucial role in performing angioplasty procedures, particularly in diagnostic and interventional cardiology. The cath labs segment holds a substantial share in the market, supported by the increasing number of catheterization procedures and the growing investment in advanced cath lab equipment.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The Angioplasty Balloons Market is characterized by intense competition among several key players operating globally. These companies compete on factors such as product quality, pricing, brand recognition, and technological innovation in order to gain a competitive edge in the market. Some of the major players in the Angioplasty Balloons Market include Abbott Laboratories, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, C. R. Bard, Inc., Cook Medical, Cordis Corporation, Endocor GmbH, and MicroPort Scientific Corporation. These companies are constantly striving to develop advanced angioplasty balloon technologies and expand their product portfolios to cater to the increasing demand for minimally invasive cardiovascular procedures. The competitive landscape in the Angioplasty Balloons Market is expected to remain dynamic and fast-paced due to ongoing technological advancements and growing investments in research and development by key market players.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Angioplasty Balloons Market — Custom Segments

Segment Sub-Segment
No segment data available.

Angioplasty Balloons Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →